Shandong Anxin Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from EDQM.
One of their notable products is TAZOBACTAM (NON-STERILE API), with a corresponding US DMF Number 33785.
Remarkably, this DMF maintains an Active status since its submission on July 17, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 21, 2019, and payment made on May 21, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II